6Schlotzer-Schrehardt U,Viestenz A,Naumann GO,et al. Doserelated structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol,2002,240:748-757.
7Krammer B. Vascular effects of photodynamic therapy. Anticancer Res,2001,21(6B): 4271-4277.
8Woodbum KW, Engelman CJ, Blumenkranz MS. Photodynamic therapy for choroidal neovascularization: a review. Retina, 2002,22:391-405;quiz 527-538.
9Verteporfin In Photodynamic Therapy Study Group. Veteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: tow-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol,2001,131:541-560.
10Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporifn: one-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol,1999,117:1329-1345.
